SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001013762-23-005134
Filing Date
2023-10-19
Accepted
2023-10-19 16:30:03
Documents
3
Group Members
VIVO ASIA OPPORTUNITY FUND HOLDINGS, L.P.VIVO ASIA OPPORTUNITY, LLCVIVO CAPITAL FUND IX, L.P.VIVO OPPORTUNITY FUND HOLDINGS, L.P.VIVO OPPORTUNITY, LLC

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D ea186991-13dvivo9_genetron.htm SC 13D 107302
2 JOINT FILING AGREEMENT ea186991ex99-1_genetron.htm EX-99.1 8901
3 ROLLOVER AND SUPPORT AGREEMENT, DATED AS OF OCTOBER 11, 2023 ea186991ex99-3_genetron.htm EX-99.3 121271
  Complete submission text file 0001013762-23-005134.txt   239260
Mailing Address 192 LYTTON AVENUE PALO ALTO CA 94301
Business Address 192 LYTTON AVENUE PALO ALTO CA 94301 6506880818
Vivo Capital IX, LLC (Filed by) CIK: 0001750698 (see all company filings)

IRS No.: 824768569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D

Mailing Address 1-2/F, BUILDING 11, ZONE 1 NO.8 LIFE SCIENCE PARKWAY CHANGPING DISTRICT, BEIJING F4 102206
Business Address 1-2/F, BUILDING 11, ZONE 1 NO.8 LIFE SCIENCE PARKWAY CHANGPING DISTRICT, BEIJING F4 102206 86 (10) 5090 7500
Genetron Holdings Ltd (Subject) CIK: 0001782594 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-92048 | Film No.: 231335044
SIC: 8071 Services-Medical Laboratories